» Articles » PMID: 37371433

Heterogenous Genetic, Clinical, and Imaging Features in Patients with Neuronal Intranuclear Inclusion Disease Carrying Repeat Expansion

Abstract

Neuronal intranuclear inclusion disease (NIID) is a neurodegenerative disorder that is caused by the abnormal expansion of non-coding trinucleotide GGC repeats in . NIID is clinically characterized by a broad spectrum of clinical presentations. To date, the relationship between expanded repeat lengths and clinical phenotype in patients with NIID remains unclear. Thus, we aimed to clarify the genetic and clinical spectrum and their association in patients with NIID. For this purpose, we genetically analyzed Japanese patients with adult-onset NIID with characteristic clinical and neuroimaging findings. Trinucleotide repeat expansions of were examined by repeat-primed and amplicon-length PCR. In addition, long-read sequencing was performed to determine repeat size and sequence. The expanded GGC repeats ranging from 94 to 361 in were found in all 15 patients. Two patients carried biallelic repeat expansions. There were marked heterogenous clinical and imaging features in NIID patients. Patients presenting with cerebellar ataxia or urinary dysfunction had a significantly larger GGC repeat size than those without. This significant association disappeared when these parameters were compared with the total trinucleotide repeat number. ARWMC score was significantly higher in patients who had a non-glycine-type trinucleotide interruption within expanded poly-glycine motifs than in those with a pure poly-glycine expansion. These results suggested that the repeat length and sequence in may partly modify some clinical and imaging features of NIID.

Citing Articles

Neuronal intranuclear inclusion disease with subclinical peripheral neuropathy: A case report.

Sun L, Zhou L, Ren L, Han C, Xue Q, Ma L Medicine (Baltimore). 2025; 103(47):e40636.

PMID: 39809216 PMC: 11596595. DOI: 10.1097/MD.0000000000040636.

References
1.
Liu Y, Chou Y, Chang F, Lee W, Guo Y, Chou C . Neuronal intranuclear inclusion disease in patients with adult-onset non-vascular leukoencephalopathy. Brain. 2022; 145(9):3010-3021. DOI: 10.1093/brain/awac135. View

2.
Jack Jr C, Bennett D, Blennow K, Carrillo M, Dunn B, Budd Haeberlein S . NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):535-562. PMC: 5958625. DOI: 10.1016/j.jalz.2018.02.018. View

3.
Okubo M, Doi H, Fukai R, Fujita A, Mitsuhashi S, Hashiguchi S . GGC Repeat Expansion of NOTCH2NLC in Adult Patients with Leukoencephalopathy. Ann Neurol. 2019; 86(6):962-968. DOI: 10.1002/ana.25586. View

4.
Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S . Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain. 2016; 139(Pt 12):3170-3186. PMC: 5382941. DOI: 10.1093/brain/aww249. View

5.
Tian Y, Zhou L, Gao J, Jiao B, Zhang S, Xiao Q . Clinical features of -related neuronal intranuclear inclusion disease. J Neurol Neurosurg Psychiatry. 2022; 93(12):1289-1298. PMC: 9685690. DOI: 10.1136/jnnp-2022-329772. View